Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lymphangioma].

M C Riché1

  • 1Service de radiologie vasculaire, hôpital Péan, Paris.

La Revue Du Praticien
|October 15, 1992
PubMed
Summary
This summary is machine-generated.

Lymphangiomas are vascular malformations with two distinct types: cystic lymphangioma, which is benign and treatable, and tissue lymphangioma, a complex infiltrating lesion. Treatment strategies differ significantly between these two forms of lymphangioma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The current management of cervico-cephalic venous malformations.

Pediatric surgery international·2013
Same author

Therapeutic approach to arteriovenous malformations of the tongue.

European radiology·1998
Same author

[Disabling calf pain in the context of venous angiodysplasia: Contribution of dynamic exploration].

Journal des maladies vasculaires·1995
Same author

[Treatment of cystic lymphangioma].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1994
Same author

Vertebral arteriovenous fistulas: a study of 49 cases and review of the literature.

Cardiovascular surgery (London, England)·1994
Same author

Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients.

International angiology : a journal of the International Union of Angiology·1993
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Vascular Malformations
  • Pediatric Surgery
  • Medical Diagnostics

Context:

  • Lymphangiomas present as two prognostically distinct vascular malformations: cystic and tissue types.
  • Cystic lymphangiomas are benign and readily treatable, often with therapeutic sclerosis.
  • Tissue lymphangiomas are deeply infiltrating, posing significant treatment challenges and potential complications.

Purpose:

  • To differentiate between cystic and tissue lymphangiomas based on their distinct prognoses and treatment modalities.
  • To highlight the efficacy of therapeutic sclerosis for cystic lymphangioma and its ineffectiveness for tissue lymphangioma.
  • To underscore the complexities and potential severity associated with tissue lymphangioma management.

Summary:

  • Lymphangioma encompasses two distinct entities: cystic lymphangioma, a benign condition amenable to therapeutic sclerosis, and tissue lymphangioma, a challenging infiltrating lesion requiring complex treatment.

Related Experiment Videos

  • Therapeutic sclerosis with ethibloc is highly effective for cystic lymphangioma, and should precede surgical intervention.
  • Tissue lymphangioma necessitates difficult and potentially disfiguring treatments, with sclerosis being ineffective.

    • Impact:

    • Clarifies diagnostic and therapeutic approaches for distinct lymphangioma subtypes.
    • Emphasizes the importance of differentiating lymphangioma types for appropriate patient management.
    • Informs clinical decision-making regarding the sequence of treatments for coexisting lymphangioma types.